switching between glp-1 agonists Frontiers Glucagon-like peptide-1 receptor: mechanisms and

Among American adults who have taken these medications, 62% said they used them both to treat a chronic condition such as diabetes or heart disease and to lose weight, including 39% who said they used the medications only to treat a chronic condition

but widespread use of these drugs is still relatively recent

Management of diabetes in pregnancy: Standards of Care in Diabetes2024

The Reflexive Nature of a Successful Weight Loss Drug The exponential rise in search trends for terms related to these drugs (GLP-1, Wegovy, Mounjaro, Ozempic) speaks to a reflexive relationship that is catalyzed by the nature of social media

Ramracheya, R